Evidence for and Against Green Tea and Turmeric in the Management of Chronic Lymphocytic Leukemia

被引：11

作者：

Bange, Erin ^{[1
]}

Timlin, Colleen ^{[1
]}

Kabel, Charlene ^{[2
]}

Svoboda, Jakub ^{[1
]}

Roeker, Lindsey ^{[2
]}

Mato, Anthony R. ^{[2
]}

机构：

[1] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Ctr CLL, Philadelphia, PA 19104 USA

[2] Mem Sloan Kettering Canc Ctr, Sect Hematol Oncol, Leukemia Serv, CLL Program, 1275 York Ave, New York, NY 10065 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷 / 10期

关键词：

CLL; Complementary and alternative medicine; Herbal medicine; Leukemia; Lymphoma; ALTERNATIVE MEDICINE USE; ORAL POLYPHENON E; RAI STAGE 0; CANCER-PATIENTS; DEATH RECEPTOR; T-CELLS; B-CELLS; COMPLEMENTARY; CURCUMIN; INHIBITION;

D O I：

10.1016/j.clml.2018.06.021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Complementary and alternative medicine (CAM) is a diverse group of medical and health care systems, practices, and products that are not generally considered part of conventional medicine. Chronic lymphocytic leukemia (CLL) is the most common leukemia diagnosed in the western hemisphere, and 16.5% to 66% of patients have reported using CAM. Most patients use spiritual/mindebody techniques and high doses of vitamins and herbs (most commonly polyphenols, including teas). We have reviewed the reported data on green tea and turmeric use in CLL patients.

引用

页码：E421 / E426

页数：6

共 67 条

[1]

[Anonymous], WHO traditional medicine strategy 2002-2005

[2] Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products [J].

Appiah-Opong, Regina ;

Commandeur, Jan N. M. ;

van Vugt-Lussenburg, Barbara ;

Vermeulen, Nico P. E. .

TOXICOLOGY, 2007, 235 (1-2) :83-91

[3] Toxicological effects of Camellia sinensis (green tea): A review [J].

Bedrood, Zeinab ;

Rameshrad, Maryam ;

Hosseinzadeh, Hossein .

PHYTOTHERAPY RESEARCH, 2018, 32 (07) :1163-1180

[4] Herbal medicine in the United States: Review of efficacy, safety, and regulation - Grand rounds at University of California, San Francisco Medical Center [J].

Bent, Stephen .

JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 (06) :854-859

[5] Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].

Bettelli, E ;

Carrier, YJ ;

Gao, WD ;

Korn, T ;

Strom, TB ;

Oukka, M ;

Weiner, HL ;

Kuchroo, VK .

NATURE, 2006, 441 (7090) :235-238

[6] Distribution of Curcumin and THC in Peripheral Blood Mononuclear Cells Isolated from Healthy Individuals and Patients with Chronic Lymphocytic Leukemia [J].

Bolger, Gordon T. ;

Licollari, Albert ;

Tan, Aimin ;

Greil, Richard ;

Pleyer, Lisa ;

Vcelar, Brigitta ;

Majeed, Muhammad ;

Sordillo, Peter .

ANTICANCER RESEARCH, 2018, 38 (01) :121-130

[7] Complementary and alternative medicine use in oncology: A questionnaire survey of patients and health care professionals [J].

Chang, Kah Hoong ;

Brodie, Rachel ;

Choong, Mei Ann ;

Sweeney, Karl J. ;

Kerin, Michael J. .

BMC CANCER, 2011, 11

[8] National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment [J].

Cheson, BD ;

Bennett, JM ;

Grever, M ;

Kay, N ;

Keating, MJ ;

OBrien, S ;

Rai, KR .

BLOOD, 1996, 87 (12) :4990-4997

[9] Medicinal benefits of green tea:: Part II.: Review of anticancer properties [J].

Cooper, R ;

Morré, J ;

Morré, DM .

JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2005, 11 (04) :639-652

[10] Medicinal benefits of green tea:: Part I.: Review of noncancer health benefits [J].

Cooper, R ;

Morré, DJ ;

Morré, DM .

JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2005, 11 (03) :521-528

← 1 2 3 4 5 6 7 →